| 000 | 01612 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515192603.0 | ||
| 264 | 0 | _c20100402 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.3109/10428190903275602 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoosmann, Peter | |
| 245 | 0 | 0 |
_aWeekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cJan 2010 |
||
| 300 |
_a149-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBendamustine Hydrochloride |
| 650 | 0 | 4 |
_aBoronic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitrogen Mustard Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aProtease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHeizmann, Marc | |
| 700 | 1 | _aKotrubczik, Nina | |
| 700 | 1 | _aWernli, Martin | |
| 700 | 1 | _aBargetzi, Mario | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 51 _gno. 1 _gp. 149-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428190903275602 _zAvailable from publisher's website |
| 999 |
_c19250363 _d19250363 |
||